Login
$DCGO
$0.20 +$0.01 (4.27%) After hours

$DCGO SEC Filings

Filed On Filing
13 Nov 2026 8-K: Departure/Election of Directors or Officers; Compensation

This TRANSITION SERVICES AND SEPARATION AGREEMENT (this “Agreement”) is entered into by and between DocGo Inc., a Delaware corporation (the “Company”), and Lee Bienstock (“Executive”). The Company and Executive are each referred to herei...

09 Nov 2026 10-Q
09 Nov 2026 8-K: Results of Operations and Financial Condition

Gross Margin Improves 280 Basis Points Over Q2 Due to Company Profitability Initiatives

05 Oct 2026 8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +3 more

Perceptive Credit Holdings IV, LP,and its successors and assigns party hereto, as Administrative Agent and as a Lender

17 Aug 2026 10-Q
17 Aug 2026 8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition

Article 1 THE MERGER................................................................................................................... 3

10 Aug 2026 NT 10-Q
31 Jul 2026 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule

On July 28, 2026, DocGo Inc. (the “Company”) received a letter from the Nasdaq Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that Nasdaq has granted the Company an additio...

28 Jul 2026 SCHEDULE 13G/A
02 Jul 2026 8-K: Regulation FD Disclosure

On June 26, 2026, the Board of Directors of DocGo Inc. (the “Company”) approved an extension of the expiration date of the Company’s current share repurchase program (“Repurchase Program”) from June 30, 2026 to December 31, 2026. As prev...

18 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders

On June 16, 2026, DocGo Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) at 12:00 p.m. Eastern Time. As of the close of business on April 20, 2026, the record date for the Annual Meeting, there wer...

14 May 2026 Form 4: Bienstock Lee, Director

Gave up 15,644 shares to cover exercise price or tax ($9.23K)

11 May 2026 10-Q
11 May 2026 8-K: Results of Operations and Financial Condition

Company Increases 2026 Revenue Guidance Based on Strong Demand for Virtual Care Services

22 Apr 2026 ARS
22 Apr 2026 DEFINITIVE ADDITIONAL MATERIALS
22 Apr 2026 Proxy statement: annual meeting on June 16, 2026

CEO pay $3.6M, down 53% · say-on-pay vote

22 Apr 2026 8-K: Departure/Election of Directors or Officers; Compensation

On April 17, 2026, Stephen K. Klasko, MD notified DocGo Inc. (the “Company”) of his decision to step down as a member of the Board of Directors (the “Board”) and his other Board and committee positions because he accepted a new significa...

10 Apr 2026 PROXY STATEMENT
31 Mar 2026 Form 4: Bienstock Lee, Director

Gave up 18,811 shares to cover exercise price or tax ($10.7K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support